Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year

Journal of Clinical Oncology

Volumn 19, Issue 6, 2001, Pages 1795-1801

  Burchill, S A ^a   Lewis, I J ^a   Abrams, K R ^a   Riley, R ^a   Imeson, J ^a   Pearson, A D J ^a   Pinkerton, R ^a   Selby, P ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; LACTATE DEHYDROGENASE; MESSENGER RNA; NEURON SPECIFIC ENOLASE; TYROSINE 3 MONOOXYGENASE;

ARTICLE; BLOOD ANALYSIS; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035868665     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.6.1795     Document Type: Article

References (30)

1. Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma
2. Detection of neuroblastoma cells in blood
3. Prognostic value of immunocytological detection of bone marrow metastases in neuroblastoma
4. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction
5. Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA
6. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA
7. Sequential detection of tumour cells in the peripheral blood and bone marrow of patients with stage IV neuroblastoma by the reverse transcription-polymerase chain reaction for TH mRNA
8. Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction
9. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction
10. Detection of low numbers of neuroblastoma cells in vitro
11. Detection of microscopic neuroblastoma in marrow by histology, immunocytology, and reverse transcription-PCR of multiple molecular markers
12. Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastoma
13. The molecular detection of tumour cells
14. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma
15. Measurement of dopamine, HVA and HMMA in untimed urine samples: Establishment of age-related reference data in children
16. Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells
17. Early detection of circulating solid tumour cells using molecular technology
18. Molecular detection of small volume disease
19. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
20. Statistical estimation of prognosis for children with neuroblastoma
21. Prognostic factors in neuroblastoma
22. Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas: A clinicopathologic study of 211 cases from the Pediatric Oncology Group
23. Serum lactate dehydrogenase in childhood neuroblastoma: A Pediatric Oncology Group recursive partitioning study
24. Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival
25. Amplification of MYCN in untreated human neuroblastomas correlates with advanced disease stage
26. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid
27. Long-term survivors of advanced neuroblastoma with MYCN amplification: A report of 19 patients surviving disease-free for more than 66 months
28. Prognostic significance of age: MYCN oncogene amplification, tumour cell ploidy and histology in 110 infants with stage D(s)neuroblastoma
29. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma
30. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma